News

Published on 7 Nov 2024 on Investing.com

Gilead Sciences' chief medical officer sells $2.34 million in stock By...


Article preview image

In recent activity reported by Gilead Sciences, Inc. (NASDAQ:GILD), Chief Medical (TASE:PMCN)...

NASDAQ.GILD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver...

On Friday, Gilead Sciences, Inc. (NASDAQ:GILD) revealed data from a two-and-a-half-year interim...

Benzinga · via AOL 15 Nov 2024

Trump's Victory Spurs $50B Corporate Bond Surge As Tax Cut Optimism Drives...

In the wake of Donald Trump’s recent election victory, companies are rushing to tap into the US b...

Benzinga 15 Nov 2024

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight

Comprehensive SWOT analysis reveals Gilead Sciences Inc's strategic positioning in the...

GuruFocus.com · via Yahoo Finance 13 Nov 2024

US FDA declines full approval for Intercept's liver disease drug

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept...

Reuters 12 Nov 2024

HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported...

Benzinga · via Yahoo Finance 7 Nov 2024

Gilead Sciences Inc (GILD) Q3 2024 Earnings Call Highlights: Strong HIV and...

Gilead Sciences Inc (GILD) reports robust Q3 performance with significant gains in HIV and oncolo...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported...

Benzinga · via AOL 7 Nov 2024

Gilead Sciences' chief medical officer sells $2.34 million in stock By...

In recent activity reported by Gilead Sciences, Inc. (NASDAQ:GILD), Chief Medical (TASE:PMCN)...

Investing.com 7 Nov 2024

Gilead’s earnings beat by a wide margin, and biotech raises guidance

Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew p...

Market Watch 6 Nov 2024

Is Gilead Sciences, Inc. (GILD) the Best Pharma Stock to Buy Right Now?

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 4 Nov 2024